MedTrace Logo

Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

NCT00599820 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-06-03

No results posted yet for this study

Summary

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks

Conditions

  • Angioid Streaks
  • Choroidal Neovascularization

Interventions

DRUG

Intravitreal Bevacizumab

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Adriana Solís-Vivanco, MD · Asociación para Evitar la Ceguera en México

  • Jans Fromow-Guerra, MD PhD · Asociación para Evitar la Ceguera en México

  • Mariana Martínez-Castellanos, MD · Asociación para Evitar la Ceguera en México

  • Elizabeth Reyna-Castelán, MD · Asociación para Evitar la Ceguera en México

  • Myriam Hernández-Rojas, MD · Asociación para Evitar la Ceguera en México

  • Griselda Alvarez-Rivera, MD · Asociación para Evitar la Ceguera en México

  • Hugo Quiroz-Mercado, MD · Asociación para Evitar la Ceguera en México

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2005-11-30
Completion
2006-05-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00599820 on ClinicalTrials.gov